Option Care Health (NASDAQ:OPCH) Updates Q4 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its fourth quarter earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.42-0.45 for the period, compared to the consensus estimate of $0.35. The company issued revenue guidance of $1.34-1.35 billion, compared to the consensus revenue estimate of $1.27 billion. Option Care Health also updated its FY25 guidance to $1.59-1.69 EPS.

Option Care Health Stock Performance

NASDAQ OPCH opened at $23.99 on Monday. The stock has a market cap of $4.08 billion, a PE ratio of 20.16, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a 50-day moving average of $23.10 and a 200-day moving average of $27.69. Option Care Health has a 52-week low of $21.39 and a 52-week high of $34.63.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on OPCH. JMP Securities restated a “market outperform” rating and set a $30.00 price objective (down previously from $31.00) on shares of Option Care Health in a report on Friday. The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and reduced their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Truist Financial lowered their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. UBS Group started coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Finally, Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and lowered their price target for the stock from $38.00 to $26.00 in a research report on Thursday, October 31st. Four research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $29.14.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares of the company’s stock, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.64% of the stock is currently owned by insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.